Drug-eluting stent thrombosis: it's never too late.
Kandzari
David E
DE
Duke Clinical Research Institute, 2400 Pratt Street, Durham, NC 27705, USA. david.kandzari@duke.edu
D006801:Humans; D015994:Incidence; D015201:Meta-Analysis as Topic; D017239:Paclitaxel / Q000009:adverse effects; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D011474:Prosthesis Design; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D020123:Sirolimus / Q000009:adverse effects; D015607:Stents / Q000009:adverse effects*; D013927:Thrombosis / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control; D013997:Time Factors
D010975:Platelet Aggregation Inhibitors; D017239:Paclitaxel; D020123:Sirolimus